Humalog
- Product NDC
- 55045-3602
- 11-digit product format
- 550453602
- Labeler code
- 55045
- Product ID
- 55045-3602_0b67b87e-09b2-4469-846e-52ea3f962018
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Insulin lispro
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- Dispensing Solutions, Inc.
- Application
- NDA020563
- Marketing category
- NDA
- Marketing start
- 1996-07-24
- Marketing end
- 0000-00-00
- Substance
- INSULIN LISPRO
- Active strength
- 100 [iU]/mL
- Pharmacologic classes
- Insulin [Chemical/Ingredient],Insulin Analog [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 55045-3602-1 | Humalog | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | | 2 |
| 55045-3602-1 | Humalog | 10 mL in 1 VIAL | INJECTION, SOLUTION | 10 | | 2 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| Insulin lispro | ACTIVE INGREDIENT | GFX7QIS1II | HUMALOG (INSULIN LISPRO) INJECTION, SOLUTION [DISPENSING SOLUTIONS, INC.] | 2 | |
| Insulin lispro | ACTIVE MOIETY | GFX7QIS1II | HUMALOG (INSULIN LISPRO) INJECTION, SOLUTION [DISPENSING SOLUTIONS, INC.] | 2 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | HUMALOG (INSULIN LISPRO) INJECTION, SOLUTION [DISPENSING SOLUTIONS, INC.] | 2 | |
| Hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | HUMALOG (INSULIN LISPRO) INJECTION, SOLUTION [DISPENSING SOLUTIONS, INC.] | 2 | |
| Metacresol | INACTIVE INGREDIENT | GGO4Y809LO | HUMALOG (INSULIN LISPRO) INJECTION, SOLUTION [DISPENSING SOLUTIONS, INC.] | 2 | |
| Phenol | INACTIVE INGREDIENT | 339NCG44TV | HUMALOG (INSULIN LISPRO) INJECTION, SOLUTION [DISPENSING SOLUTIONS, INC.] | 2 | |
| Sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | HUMALOG (INSULIN LISPRO) INJECTION, SOLUTION [DISPENSING SOLUTIONS, INC.] | 2 | |
| Sodium Phosphate, Dibasic | INACTIVE INGREDIENT | GR686LBA74 | HUMALOG (INSULIN LISPRO) INJECTION, SOLUTION [DISPENSING SOLUTIONS, INC.] | 2 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | HUMALOG (INSULIN LISPRO) INJECTION, SOLUTION [DISPENSING SOLUTIONS, INC.] | 2 | |
| Zinc | INACTIVE INGREDIENT | J41CSQ7QDS | HUMALOG (INSULIN LISPRO) INJECTION, SOLUTION [DISPENSING SOLUTIONS, INC.] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 55045-3602 | HUMALOG (INSULIN LISPRO) INJECTION, SOLUTION [DISPENSING SOLUTIONS, INC.] | 2 | Legacy NDC, 2 package rows | 20120928_c5f75765-86b8-4926-b8c3-b42133ca7ac8.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 55045-3602-1 | 55045360201 | 1 in 1 CARTON | Historical |